BindingDB logo
myBDB logout

28 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28089350 8 Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.EBI Northern Illinois University
23582273 12 Synthesis and antitumor activity of 1,3,4-oxadiazole possessing 1,4-benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors.EBI Nanjing University
23634668 97 Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells.EBI Johns Hopkins University School of Medicine
20691509 47 QSAR study of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2 using LS-SVM and GRNN based on principal components.EBI Kermanshah University of Medical Sciences
20621724 50 Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors.EBI Universit£t Heidelberg
19209899 9 A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products.EBI University of California Santa Cruz
14684305 11 Investigation of novel fumagillin analogues as angiogenesis inhibitors.EBI Gilead Sciences
21925884 16 Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors.EBI Nanjing University
18457385 41 Recent developments in fragment-based drug discovery.EBI Astex Therapeutics Ltd.
16970390 6 Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.EBI The Johns Hopkins University School of Medicine
15149671 22 Design and synthesis of beta-amino-alpha-hydroxy amide derivatives as inhibitors of MetAP2 and HUVEC growth.EBI Celera
15012983 169 3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2.EBI Abbott Laboratories
14684302 8 Peptidyl hydroxamic acids as methionine aminopeptidase inhibitors.EBI The Ohio State University
12877582 3 Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.EBI Johns Hopkins University School of Medicine
26686773 24 Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity.BDB German Cancer Research Center (DKFZ)
17656313 14 Regulation of c-Src nonreceptor tyrosine kinase activity by bengamide A through inhibition of methionine aminopeptidases.BDB The Johns Hopkins University
9224570 23 Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.BDB Massachusetts Institute of Technology
17114291 10 Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression.BDB Johns Hopkins University
17350258 27 Lead optimization of methionine aminopeptidase-2 (MetAP2) inhibitors containing sulfonamides of 5,6-disubstituted anthranilic acids.BDB Abbott Laboratories
16632353 14 Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties.BDB Abbott Laboratories
14633714 18 Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.BDB Abbott Laboratories
16789740 109 Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding.BDB Abbott Laboratories
16134930 30 4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo.BDB GSK
17636946 94 Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore.BDB GSK